Literature DB >> 32391416

Mapping the breakome reveals tight regulation on oncogenic super-enhancers.

Sara Oster1, Rami I Aqeilan1,2.   

Abstract

DNA double-strand breaks (DSBs) could be deleterious and lead to age-related diseases, such as cancer. Recent evidence, however, associates DSBs with vital cellular processes. As discussed here, genome-wide mapping of DSBs revealed an unforeseen coupling mechanism between transcription and DNA repair at super-enhancers, as means of hypertranscription of oncogenic drivers.
© 2020 Taylor & Francis Group, LLC.

Entities:  

Keywords:  BLISS; DSBs; RAD51; breakome; super-enhancer

Year:  2020        PMID: 32391416      PMCID: PMC7199745          DOI: 10.1080/23723556.2019.1698933

Source DB:  PubMed          Journal:  Mol Cell Oncol        ISSN: 2372-3556


  9 in total

Review 1.  DNA topoisomerase II and its growing repertoire of biological functions.

Authors:  John L Nitiss
Journal:  Nat Rev Cancer       Date:  2009-04-20       Impact factor: 60.716

2.  Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element.

Authors:  Marc R Mansour; Brian J Abraham; Lars Anders; Alla Berezovskaya; Alejandro Gutierrez; Adam D Durbin; Julia Etchin; Lee Lawton; Stephen E Sallan; Lewis B Silverman; Mignon L Loh; Stephen P Hunger; Takaomi Sanda; Richard A Young; A Thomas Look
Journal:  Science       Date:  2014-11-13       Impact factor: 47.728

3.  Genome Organization Drives Chromosome Fragility.

Authors:  Andres Canela; Yaakov Maman; Seolkyoung Jung; Nancy Wong; Elsa Callen; Amanda Day; Kyong-Rim Kieffer-Kwon; Aleksandra Pekowska; Hongliang Zhang; Suhas S P Rao; Su-Chen Huang; Peter J Mckinnon; Peter D Aplan; Yves Pommier; Erez Lieberman Aiden; Rafael Casellas; André Nussenzweig
Journal:  Cell       Date:  2017-07-20       Impact factor: 41.582

Review 4.  Endogenous DNA Damage as a Source of Genomic Instability in Cancer.

Authors:  Anthony Tubbs; André Nussenzweig
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

5.  Master transcription factors and mediator establish super-enhancers at key cell identity genes.

Authors:  Warren A Whyte; David A Orlando; Denes Hnisz; Brian J Abraham; Charles Y Lin; Michael H Kagey; Peter B Rahl; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

6.  BLISS is a versatile and quantitative method for genome-wide profiling of DNA double-strand breaks.

Authors:  Winston X Yan; Reza Mirzazadeh; Silvano Garnerone; David Scott; Martin W Schneider; Tomasz Kallas; Joaquin Custodio; Erik Wernersson; Yinqing Li; Linyi Gao; Yana Federova; Bernd Zetsche; Feng Zhang; Magda Bienko; Nicola Crosetto
Journal:  Nat Commun       Date:  2017-05-12       Impact factor: 14.919

7.  Activation of Oncogenic Super-Enhancers Is Coupled with DNA Repair by RAD51.

Authors:  Idit Hazan; Jonathan Monin; Britta A M Bouwman; Nicola Crosetto; Rami I Aqeilan
Journal:  Cell Rep       Date:  2019-10-15       Impact factor: 9.423

8.  Transcriptional elongation requires DNA break-induced signalling.

Authors:  Heeyoun Bunch; Brian P Lawney; Yu-Fen Lin; Aroumougame Asaithamby; Ayesha Murshid; Yaoyu E Wang; Benjamin P C Chen; Stuart K Calderwood
Journal:  Nat Commun       Date:  2015-12-16       Impact factor: 14.919

9.  Transcriptionally active chromatin recruits homologous recombination at DNA double-strand breaks.

Authors:  François Aymard; Beatrix Bugler; Christine K Schmidt; Emmanuelle Guillou; Pierre Caron; Sébastien Briois; Jason S Iacovoni; Virginie Daburon; Kyle M Miller; Stephen P Jackson; Gaëlle Legube
Journal:  Nat Struct Mol Biol       Date:  2014-03-23       Impact factor: 18.361

  9 in total
  2 in total

Review 1.  Programmed DNA Damage and Physiological DSBs: Mapping, Biological Significance and Perturbations in Disease States.

Authors:  Sara Oster; Rami I Aqeilan
Journal:  Cells       Date:  2020-08-10       Impact factor: 6.600

Review 2.  Targeting DNA Damage Response in Prostate and Breast Cancer.

Authors:  Antje M Wengner; Arne Scholz; Bernard Haendler
Journal:  Int J Mol Sci       Date:  2020-11-04       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.